BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/27/2024 10:57:17 AM | Browse: 266 | Download: 1159
Publication Name World Journal of Methodology
Manuscript ID 99300
Country India
ISSN 2222-0682 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Anesthesiology
Manuscript Type Meta-Analysis
Article Title Comparative efficacy of hyperbaric bupivacaine vs hyperbaric ropivacaine in spinal anesthesia for cesarean section: A meta-analysis
Manuscript Source Invited Manuscript
All Author List Rishi Anand, Deb Sanjay Nag, Roushan Patel, Prashant Sharma, Vamsi Krishna Uppalapati and Umesh Kumar Singh
ORCID
Author(s) ORCID Number
Deb Sanjay Nag http://orcid.org/0000-0003-2200-9324
Funding Agency and Grant Number
Corresponding Author Deb Sanjay Nag, MD, Department of Anaesthesiology, Tata Main Hospital, C Road West, Northern Town, Bistupur, Jamshedpur 831001, Jhārkhand, India. ds.nag@tatasteel.com
Key Words Ropivacaine; Bupivacaine; Anesthesia; Spinal; Cesarean section; Meta-analysis
Core Tip Hyperbaric bupivacaine had been the standard local anesthetic drug for spinal anesthesia in caesarean sections. Its drawbacks include high incidences of adverse events (hypotension, nausea) and delayed ambulation. Ropivacaine, a newer local anesthetic agent, offers potential advantages such as improved safety and shorter motor blockade duration. Recent marketing of heavy ropivacaine has reignited interest in this. This meta-analysis compares the hyperbaric preparation of ropivacaine and bupivacaine in the context of spinal anesthesia for cesarean sections. This analysis aims to shed light on the comparative benefits of these agents, paving the way for informed decision-making in obstetric anesthesia practices.
Publish Date 2024-11-27 10:57
Citation

Anand R, Nag DS, Patel R, Sharma P, Uppalapati VK, Singh UK. Comparative efficacy of hyperbaric bupivacaine vs hyperbaric ropivacaine in spinal anesthesia for cesarean section: A meta-analysis. World J Methodol 2025; 15(2): 99300

URL https://www.wjgnet.com/2222-0682/full/v15/i2/99300.htm
DOI https://dx.doi.org/10.5662/wjm.v15.i2.99300
Full Article (PDF) WJM-15-99300-with-cover.pdf